n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Alloxan Diabetes in 4 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Atorvastatin treatment did not affect glycemia levels." | 1.43 | Treatment with high dose of atorvastatin reduces vascular injury in diabetic rats. ( Botelho, T; de Batista, PR; Padilha, AS; Ribeiro-Júnior, RF; Simões, FV; Vassallo, DV, 2016) |
| "Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease believed to be caused by an inflammatory process in the pancreas leading to selective destruction of the beta cells." | 1.31 | COX-2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin-treated mice. ( Floyd, RA; Jacob, JM; Kotake, Y; Tabatabaie, T; Waldon, AM, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simões, FV | 1 |
| de Batista, PR | 1 |
| Botelho, T | 1 |
| Ribeiro-Júnior, RF | 1 |
| Padilha, AS | 1 |
| Vassallo, DV | 1 |
| Nacci, C | 1 |
| Tarquinio, M | 1 |
| De Benedictis, L | 1 |
| Mauro, A | 1 |
| Zigrino, A | 1 |
| Carratù, MR | 1 |
| Quon, MJ | 1 |
| Montagnani, M | 1 |
| Ramos-Alves, FE | 1 |
| de Queiroz, DB | 1 |
| Santos-Rocha, J | 1 |
| Duarte, GP | 1 |
| Xavier, FE | 1 |
| Tabatabaie, T | 1 |
| Waldon, AM | 1 |
| Jacob, JM | 1 |
| Floyd, RA | 1 |
| Kotake, Y | 1 |
4 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Alloxan Diabetes
| Article | Year |
|---|---|
Treatment with high dose of atorvastatin reduces vascular injury in diabetic rats.
Topics: Animals; Aorta; Atorvastatin; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Endothelium, Vascul | 2016 |
Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature.
Topics: Animals; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diabetes Mellitus, Experime | 2009 |
Increased cyclooxygenase-2-derived prostanoids contributes to the hyperreactivity to noradrenaline in mesenteric resistance arteries from offspring of diabetic rats.
Topics: Animals; Cells, Cultured; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Dinoprost; Endothelial | 2012 |
COX-2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin-treated mice.
Topics: Animals; Blood Glucose; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Di | 2000 |